Feature Channels: Blood

Filters close
Released: 11-Feb-2024 9:05 PM EST
Black women in the US murdered six times more often than White women over last 20 years
Columbia University, Mailman School of Public Health

Black women in the U.S were, on average, six times more likely to be murdered than their white peers for the years 1999 through 2020, according to an analysis of racial disparities in U.S. homicide rates released by Columbia University Irving Medical Center and Columbia’s Mailman School of Public Health.

Newswise: Yang%20image%20%281%29.png
5-Feb-2024 8:00 AM EST
3D Ice Printing can Create Artificial Blood Vessels in Engineered Tissue
Biophysical Society

Over 100,000 individuals in the United States are currently in need of organ transplants. The demand for organs, such as hearts, kidneys, and livers, far exceeds the available supply and people sometimes wait years to receive a donated organ.

   
Newswise: International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
9-Feb-2024 9:05 AM EST
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
University Hospitals Cleveland Medical Center

In a major, international study, named SELECT2, a University Hospitals (UH) research team found that patients with large strokes had a dramatically better recovery after endovascular thrombectomy plus medical management at long-term follow-up, than patients who only received standard medical management.

Newswise: Harnessing Human Evolution to Advance Precision Medicine
Released: 9-Feb-2024 3:05 PM EST
Harnessing Human Evolution to Advance Precision Medicine
University of California San Diego

Scientists hope to advance precision medicine through the discovery of a gene variant that leads to the same phenotype in separate high-dwelling populations while taking a different evolutionary path.

Released: 9-Feb-2024 10:05 AM EST
Moffitt Develops First Individualized Predictive Model for Multiple Myeloma Treatment
Moffitt Cancer Center

In a new article published in the Journal of Clinical Oncology, Moffitt Cancer Center researchers in collaboration with Sylvester Comprehensive Cancer Center and groups around the world share results from a novel model that can provide tailored predictions of how individual patients respond to different therapies.

Released: 8-Feb-2024 5:05 PM EST
Fibroblasts in the penis are more important for erectile function than previously thought
Karolinska Institute

Regular erections could be important for maintaining erectile function, according to a new study on mice published in Science by researchers at Karolinska Institutet.

Released: 8-Feb-2024 3:00 PM EST
Novel Treatment Regimen for FLT3-Mutated Acute Myeloid Leukemia Shows Promise in Roswell Park-Led Study
Roswell Park Comprehensive Cancer Center

Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis.

Newswise: Blood test predicts psychosis risk, most effective treatments
Released: 8-Feb-2024 10:05 AM EST
Blood test predicts psychosis risk, most effective treatments
Indiana University

Team of researchers led by Indiana University School of Medicine faculty have developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions.

Newswise: Treatment-with-ISRIB-a-small-molecule_ALT_6x4.jpg
Released: 8-Feb-2024 8:55 AM EST
Clues to cancer drug’s deadly side effects could make it safer
University of Illinois Chicago

For some leukemia patients, their only treatment option carries a risk of heart failure

Released: 8-Feb-2024 8:00 AM EST
Unveiling potential diagnostic, treatment target for APS-related thrombocytopenia
Michigan Medicine - University of Michigan

No standard treatment exists for thrombocytopenia in patients with antiphospholipid syndrome, but this could change with a new treatment target

Newswise: 1920_cedars-sinai-cancer-research.jpg?10000
Released: 7-Feb-2024 11:05 AM EST
RESEARCH ALERT: Stopping Multiple Myeloma
Cedars-Sinai

Cedars-Sinai Cancer investigators have discovered a protein expressed on multiple myeloma cancer cells that drives disease growth and development. The new study found that blocking part of the protein’s unique signaling pathway stops myeloma growth in culture and in laboratory mice.

Newswise: Johns Hopkins Researchers Make Progress Toward Developing Blood Tests for Psychiatric and Neurological Disorders
Released: 7-Feb-2024 10:00 AM EST
Johns Hopkins Researchers Make Progress Toward Developing Blood Tests for Psychiatric and Neurological Disorders
Johns Hopkins Medicine

Researchers in a Johns Hopkins Children’s Center-led study say they have made progress in developing a blood test to identify disease-associated changes in the brain specifically linked to postpartum depression and other psychiatric and neurological disorders.

Released: 6-Feb-2024 10:05 AM EST
AI-powered projects targeting blindness, cervical cancer selected for Penn Medicine accelerator program
Perelman School of Medicine at the University of Pennsylvania

Through the use of artificial intelligence, teams hope to better check for diabetic retinopathy and improve the process of cervical cancer screenings

Released: 6-Feb-2024 9:30 AM EST
Physician Scientists Underrepresented in Medicine to Conduct Health Equity Research at Montefiore and Einstein
Albert Einstein College of Medicine and Montefiore Health System

Montefiore Health System and Albert Einstein College of Medicine have been awarded a $1.5 million National Institutes of Health grant to provide advanced research training to post-graduate trainees from groups that are underrepresented in medicine and have research interests in heart, lung, blood, and sleep disorders. Over five years, nine researchers will receive intense research training and robust mentorship from almost 30 established, senior investigators across Montefiore and Einstein.

Newswise: Awards totaling $2.6 Million Support Exploration of Therapeutic Strategy for Adult and Pediatric T-cell Acute Lymphoblastic Leukemia
Released: 6-Feb-2024 8:05 AM EST
Awards totaling $2.6 Million Support Exploration of Therapeutic Strategy for Adult and Pediatric T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a total of $2.6M to support his research on acute lymphoblastic leukemia (ALL), an aggressive type of leukemia that affects both children and adults.

Newswise: Spiky insight: How red blood cells deform
Released: 6-Feb-2024 2:05 AM EST
Spiky insight: How red blood cells deform
Empa, Swiss Federal Laboratories for Materials Science and Technology

Empa researchers have observed living red blood cells transforming into spiky "echinocytes" in real time when treated with high concentrations of ibuprofen using holotomographic microscopy and displayed them in 3D renderings.

Newswise: A rare recent case of retrovirus integration: An infectious gibbon ape leukaemia virus is colonising a rodent’s genome in New Guinea
Released: 5-Feb-2024 10:05 PM EST
A rare recent case of retrovirus integration: An infectious gibbon ape leukaemia virus is colonising a rodent’s genome in New Guinea
Forschungsverbund Berlin e.V.

Retroviruses are viruses that multiply by incorporating their genes into the genome of a host cell. If the infected cell is a germ cell, the retrovirus can then be passed on to the next generation as an “endogenous” retrovirus (ERV) and spread as part of the host genome in that host species.

   
Newswise: Tracking radioactive source recovery: New Cesium Irradiator Replacement Project Dashboard
Released: 5-Feb-2024 9:30 AM EST
Tracking radioactive source recovery: New Cesium Irradiator Replacement Project Dashboard
Idaho National Laboratory (INL)

People often think of radiation as the basis for carbon-free nuclear power. But radiation can also save lives.

   
Newswise: UT Southwestern molecular geneticist wins Hill Prize from TAMEST
Released: 5-Feb-2024 9:30 AM EST
UT Southwestern molecular geneticist wins Hill Prize from TAMEST
UT Southwestern Medical Center

Russell DeBose-Boyd, Ph.D., Professor of Molecular Genetics at UT Southwestern Medical Center, has been awarded the Hill Prize in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of his long-standing research into a key mechanism necessary for cholesterol control.

Released: 2-Feb-2024 1:40 PM EST
Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes
Roswell Park Comprehensive Cancer Center

As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies.

Newswise: How Two Sisters Continue to Soar with Sickle Cell Disease
Released: 2-Feb-2024 9:30 AM EST
How Two Sisters Continue to Soar with Sickle Cell Disease
University of North Carolina Health Care System

Sydney and Sheridan Taylor of Durham, North Carolina, have lived with this rare genetic disorder all of their lives.

Newswise: Targeting Treatment Resistance in Chronic Lymphocytic Leukemia
28-Jan-2024 8:00 PM EST
Targeting Treatment Resistance in Chronic Lymphocytic Leukemia
Sylvester Comprehensive Cancer Center

New research has identified a next-generation BTK degrader that could help overcome treatment resistance in CLL and related blood cancers.

Newswise: UNC Hospitals Performs First Domino Liver Transplant in Decades
Released: 1-Feb-2024 10:05 AM EST
UNC Hospitals Performs First Domino Liver Transplant in Decades
University of North Carolina Health Care System

Chirag Desai, MD, FACS, an abdominal organ transplant and hepatobiliary-pancreatic surgeon at UNC Hospitals, performed a “domino” liver transplant, which helped two patients from a single donor without splitting a liver.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Released: 30-Jan-2024 9:45 AM EST
JMIR Perioperative Medicine Invites Submissions on Perioperative Blood Management
JMIR Publications

JMIR Publications is pleased to announce a new theme issue titled “Perioperative Blood Management” in JMIR Perioperative Medicine.

   
Newswise: RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Released: 29-Jan-2024 12:05 PM EST
RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Elsevier

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous leukemia, reports The Journal of Molecular Diagnostics.

Released: 29-Jan-2024 10:05 AM EST
Is lung cancer treatment working? This chip can tell from a blood draw
University of Michigan

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient's blood to determine how well a treatment is working by the fourth week, according to a new University of Michigan study.

Newswise: Hydroxyurea significantly reduces infections in children with sickle cell anemia
Released: 29-Jan-2024 9:05 AM EST
Hydroxyurea significantly reduces infections in children with sickle cell anemia
Indiana University

IU School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia, which enhances strong evidence of hydroxyurea’s effectiveness and could ultimately reduce death in children in Africa.

24-Jan-2024 8:00 AM EST
Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer
The Society of Thoracic Surgeons

In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).

Newswise: MU study shows blood pressure drug can reduce anxiety for people with autism
Released: 23-Jan-2024 5:05 PM EST
MU study shows blood pressure drug can reduce anxiety for people with autism
University of Missouri, Columbia

A new study at the University of Missouri’s Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD).

Released: 22-Jan-2024 1:05 PM EST
Scientists Identify Mutations That Cause Inherited Kidney Disease
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine and the First Faculty of Medicine of Charles University in Prague, Czech Republic, have discovered a new genetic cause of inherited kidney disease.

Newswise: Experts Recommend Caution on the Use of Non-Sugar Sweeteners
Released: 22-Jan-2024 11:10 AM EST
Experts Recommend Caution on the Use of Non-Sugar Sweeteners
George Washington University

Despite ongoing concerns about the health impacts of non-sugar sweeteners such as aspartame, sucralose and stevia, these sweeteners are increasingly found in a variety of foods and beverages, including those aimed at children.

Newswise: Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Released: 22-Jan-2024 11:05 AM EST
Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Cedars-Sinai

Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival.

Released: 22-Jan-2024 4:00 AM EST
Uncovering Language Disparity of ChatGPT on Retinal Vascular Disease Classification: Cross-Sectional Study
Journal of Medical Internet Research

Background: Benefiting from rich knowledge and the exceptional ability to understand text, large language models like ChatGPT have shown great potential in English clinical environments. However, the performance of ChatGPT in non-Eng...

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Released: 19-Jan-2024 9:05 AM EST
Wren Laboratories Dr. Mark Kidd to speak at 2024 Precision Medicine World Conference
Wren Laboratories

The presentation will focus on the use of mRNA in Liquid Biopsies as a platform for precision diagnostics

Released: 19-Jan-2024 7:05 AM EST
Researchers improve blood tests’ ability to detect and monitor cancer
Massachusetts Institute of Technology (MIT)

Tumors constantly shed DNA from dying cells, which briefly circulates in the patient’s bloodstream before it is quickly broken down.

Newswise: UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
Released: 18-Jan-2024 6:05 PM EST
UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
University of Texas Health Science Center at Houston

A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.

Newswise: Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker
Released: 18-Jan-2024 4:05 PM EST
Researcher, Through Spinoff, Develops a Handheld White Blood Cell Tracker
Rutgers University-New Brunswick

A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person’s white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels. T

17-Jan-2024 5:00 AM EST
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

Newswise: The Medical Minute: Calling all blood donors – especially young ones
Released: 17-Jan-2024 2:05 PM EST
The Medical Minute: Calling all blood donors – especially young ones
Penn State Health

Blood banks are looking for donors everywhere, but if you’re 17 to 35, step to the front of the line. A Penn State Health expert discusses why younger donors are needed more than ever.

Released: 17-Jan-2024 10:05 AM EST
Researchers Identify Key Characteristics Associated with Improved CAR T Outcomes in Large B Cell Lymphoma
Moffitt Cancer Center

Axi-cel CAR T targets the CD19 molecule on large B-cell lymphoma cells. The ZUMA-7 trial demonstrated that axi-cel reduced the risk of disease progression, the need for new therapy, or death by 60% compared to standard therapy. Despite these positive outcomes in event-free survival and overall survival, some patients did not respond well to therapy or relapsed quickly after treatment. Researchers wanted to assess if there were specific tumor characteristics associated with improved outcomes that could better inform treatment selection. Their findings were published today in Nature Medicine.

Newswise: RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Released: 16-Jan-2024 5:05 AM EST
RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Scientific Project Lomonosov

RUDN University doctors discovered that the body’s response to inflammation depends on individual sensitivity or resistance to oxygen deficiency.



close
1.43046